Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2009. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2786586011 | Parenteral form flucytosine (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2792323016 | Parenteral form flucytosine | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488041018 | Product containing flucytosine in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3496847014 | Product containing flucytosine in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3496848016 | Flucytosine in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3710020010 | Product containing flucytosine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3710021014 | Flucytosine-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing flucytosine in parenteral dose form (medicinal product form) | Is a | Product containing flucytosine | true | Inferred relationship | Existential restriction modifier | ||
| Product containing flucytosine in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing flucytosine in parenteral dose form (medicinal product form) | Has active ingredient | Flucytosine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing flucytosine in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing flucytosine in parenteral dose form (medicinal product form) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Flucytosine 10mg/mL infusion solution 250mLvial | Is a | False | Product containing flucytosine in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely flucytosine 2.5 gram/250 milliliter conventional release solution for infusion bottle | Is a | False | Product containing flucytosine in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only flucytosine in parenteral dose form (medicinal product form) | Is a | True | Product containing flucytosine in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR